Navigation Links
American Heart Month: Find New Heart Disease Treatments on cureLauncher

Bloomfield Hills, MI (PRWEB) February 07, 2013

Heart disease kills an estimated 630,000 Americans each year. It’s the leading cause of death for both men and women, according to the American Heart Association. To prevent heart disease and increase awareness of its affects, cureLauncher is proudly participating in American Heart Month.

cureLauncher simplifies the clinical trial enrollment process,” said President Stephen Goldner. “Anyone can now find easy-to-understand information about trials and determine if a new treatment is right for them. We’ve translated the complex, medical terminology so it’s easy to understand. cureLauncher provides a search engine to show people which trials they can look into.”

On cureLauncher, people find information about clinical trials and review the entry questions to see if it’s right for them. They can complete the Request Form to participate or call cureLauncher to talk to a relationship manager. This service is free to all users.

“cureLauncher makes it easy for people to find treatment that’s right for them,” said Vice President David Fuehrer. “Knowing where to look for treatment can be a scary process. That’s why we created a place where people feel comfortable learning about clinical trials and cutting edge, new medical treatments.”

You are at higher risk of heart disease if you are: a woman age 55 or older, a man age 45 or older, or a person with a family history of early heart disease, according to the American Heart Association.

To more information, visit

About CureLauncher is an online community that connects people to lifesaving clinical trials across the U.S. Discover your power to find new, lifesaving medical treatments, right now.

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. American Physical Society elected physicist Markus Aspelmeyer as a Fellow
2. Natac Adopts Olive through the American Botanical Councils Adopt-an-Herb Program
3. Bayer CropScience Invites Young Americans to the Table to Help Solve the Issue of Feeding a Hungry Planet
4. DuPont, American Farm Bureau Foundation Invests $250,000 in My American Farm Web Education Program
5. DMG Productions to Feature Pro Mags LLC in an Upcoming Episode of American Farmer
6. Life Products Company to be Featured in Upcoming Episode of American Farmer, Produced by DMG Productions
7. American Journal of Infection Control Study Validates ATP Testing for Monitoring Sanitation in Hospitals; Charm Sciences Test Verified
8. Analysis of Venture Capital Investment Trends in the North American and European Healthcare Industry
9. Array BioPharma Provides Updates On Clinical Data At The 2012 American Society Of Hematology Meeting
10. Data Presented at American Society of Hematology from Ibrutinib Phase 1b/2 and Phase 2 Trials Suggest High and Durable Response in Chronic Lymphocytic Leukemia
11. Amgen Highlights Data To Be Presented At American Society of Hematology Annual Meeting
Post Your Comments:
(Date:11/27/2015)... CHESTERFIELD, United Kingdom , Nov. 27, 2015 /PRNewswire/--  ... specialty biopharmaceutical company, announced today that it has closed ... systems (CMDS) business to Guerbet (GBT- NYSE Euronext) in ... CMDS operations encompassed four manufacturing facilities and a total ... nearly 75 in the St. Louis ...
(Date:11/27/2015)... November 27, 2015 ... popularity of companion diagnostics is one of ... market with pharmaceutical companies and diagnostic manufacturers ... tests. . --> ... report on global cancer biomarkers market spread ...
(Date:11/26/2015)... , November 26, 2015 --> ... company specializing in imaging technologies, announced today that it has ... part of the Horizon 2020 European Union Framework Programme for ... large-scale clinical trial in breast cancer. , ... --> --> The study ...
(Date:11/25/2015)... Nov. 25, 2015  PharmAthene, Inc. (NYSE MKT: PIP) ... a stockholder rights plan (Rights Plan) in an effort ... carryforwards (NOLs) under Section 382 of the Internal Revenue ... PharmAthene,s use of its NOLs could be substantially ... defined in Section 382 of the Code. In general, ...
Breaking Biology Technology:
(Date:11/12/2015)... , Nov. 12, 2015  A golden retriever ... Duchenne muscular dystrophy (DMD) has provided a new lead ... Children,s Hospital, the Broad Institute of MIT and Harvard ... Brazil . Cell, pinpoints ... dogs "escape" the disease,s effects. The Boston Children,s lab ...
(Date:11/10/2015)... , Nov. 10, 2015 ... biometrics that helps to identify and verify the ... is considered as the secure and accurate method ... of a particular individual because each individual,s signature ... results especially when dynamic signature of an individual ...
(Date:10/29/2015)... Minn. , Oct. 29, 2015   MedNet ... supports the entire spectrum of clinical research, is pleased ... Minnesota High Tech Association (MHTA) as one of only ... in the "Software – Small and Growing" category. The Tekne ... individuals who have shown superior technology innovation and leadership. ...
Breaking Biology News(10 mins):